Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients

被引：0
作者：
Guan-Hui Zhou
Jun Han
Jun-Hui Sun
Yue-Lin Zhang
Tan-Yang Zhou
Chun-Hui Nie
Tong-Yin Zhu
Sheng-Qun Chen
Bao-Quan Wang
Zi-Niu Yu
Hong-Liang Wang
Li-Ming Chen
Wei-Lin Wang
Shu-Sen Zheng
机构：
[1] The First Affiliated Hospital,Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery
[2] College of Medicine,Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases
[3] Zhejiang University,undefined
[4] Key Laboratory of Combined Multi-organ Transplantation,undefined
[5] Ministry of Public Health,undefined
[6] Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province,undefined
[7] Zhejiang University,undefined
来源：
BMC Cancer | / 18卷
关键词：
DEB-TACE; CalliSpheres®; Hepatocellular carcinoma (HCC); Efficacy; Safety; Predictive factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients
    Peng, Ning
    Mao, Linfeng
    Tao, Yiwen
    Xiao, Kaiyin
    Yuan, Guandou
    He, Songqing
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [42] A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma
    van Malenstein, Hannah
    Maleux, Geert
    Vandecaveye, Vincent
    Heye, Sam
    Laleman, Wim
    van Pelt, Jos
    Vaninbroukx, Johan
    Nevens, Frederik
    Verslype, Chris
    ONKOLOGIE, 2011, 34 (07): : 368 - 376
  • [43] Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
    Shao, Guoliang
    Wang, Jingwen
    Zhou, Xiaoying
    Sun, Guojun
    Dong, Zuojun
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [44] Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma
    Pawlik, Timothy M.
    Reyes, Diane K.
    Cosgrove, David
    Kamel, Ihab R.
    Bhagat, Nikhil
    Geschwind, Jean-Francois H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (30) : 3960 - 3967
  • [45] Transarterial chemoembolization for hepatocellular carcinoma: quality of life, tumour response, safety and survival comparing two types of drug-eluting beads
    Grumme, Janek
    Werncke, Thomas
    Meine, Timo C.
    Becker, Lena S.
    Kloeckner, Roman
    Maschke, Sabine K.
    Kirstein, Martha M.
    Vogel, Arndt
    Wacker, Frank K.
    Meyer, Bernhard C.
    Hinrichs, Jan B.
    Rodt, Thomas
    ABDOMINAL RADIOLOGY, 2020, 45 (10) : 3326 - 3336
  • [46] Treatment response, survival and safety profile of transarterial chemoembolization using different sizes of drug-eluting beads in hepatocellular carcinoma patients with portal vein tumor thrombus
    Lyu, Tianshi
    Yao, Hang
    Wang, Jian
    Song, Li
    Tong, Xiaoqiang
    Zou, Yinghua
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (04)
  • [47] Comparison of the Treatment Response of Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
    Adel, Hatem
    Shazlee, Muhammad K.
    Qamar, Saqib
    Hyder, Syed Muhammad Shahnawaz
    Razaque, Abdul
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [48] Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients
    Chen, Changyong
    Qiu, Huaiming
    Yao, Yuanhui
    Zhang, Zishu
    Ma, Cong
    Ma, Yilong
    Zhao, Chang
    Xiang, Hua
    Zhao, Hui
    Zheng, Chuansheng
    Xiong, Bin
    Li, Haiping
    Long, Qingyun
    Zhou, Jun
    Luo, Chao
    Hu, Hongyao
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (02)
  • [49] Comparison of treatment response, survival and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres® microspheres versus conventional transarterial chemoembolization in treating hepatocellular carcinoma
    Zhao, Chang
    Pei, Shenglin
    Chen, Zuyi
    Ma, Yilong
    JOURNAL OF BUON, 2019, 24 (03): : 1150 - 1166
  • [50] Drug-eluting bead transarterial chemoembolization is efficient and well-tolerated in treating elderly Chinese hepatocellular carcinoma patients
    Zhou, Yiming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (10): : 4867 - 4878
12345